![Thomas Gad](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Thomas Gad is the founder of Singad Pharma Aps, founded in 2003.
Mr. Gad was the founder of Y-mAbs Therapeutics, Inc., founded in 2015, holding the title of Vice Chairman & Chief Business Officer from 2023 to 2025.
Education includes an undergraduate degree from Pepperdine University.
Anciens postes connus de Thomas Gad
| Sociétés | Poste | Fin |
|---|---|---|
| YMAS THER | Directeur Général | 06/11/2023 |
Singad Pharma Aps | Fondateur | 01/01/2013 |
Formation de Thomas Gad
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
27
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Pepperdine University
 Pepperdine University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Singad Pharma Aps | |
Y-mAbs Therapeutics, Inc.
 Y-mAbs Therapeutics, Inc. BiotechnologyHealth Technology Develops radioimmunotherapy and antibody-based oncology therapies for treating cancer | Health Technology |
